Original studies evaluating radiomics models for predicting KRAS mutation status in lung cancer patients were identified through systematic searches of databases including PubMed, Embase, China National Knowledge Infrastructure (CNKI), Web of Science, and the Cochrane Library (from inception to June 2025). The gene discussed is KRAS; the disease is lung carcinoma.